Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.2 billion.

  • Agilon Health's Total Current Liabilities fell 1201.26% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1201.26%. This contributed to the annual value of $1.2 billion for FY2024, which is 1789.38% up from last year.
  • As of Q3 2025, Agilon Health's Total Current Liabilities stood at $1.2 billion, which was down 1201.26% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Total Current Liabilities registered a high of $1.5 billion during Q1 2024, and its lowest value of $357.0 million during Q4 2021.
  • In the last 5 years, Agilon Health's Total Current Liabilities had a median value of $977.2 million in 2023 and averaged $943.4 million.
  • Per our database at Business Quant, Agilon Health's Total Current Liabilities surged by 12515.01% in 2023 and then tumbled by 1201.26% in 2025.
  • Over the past 5 years, Agilon Health's Total Current Liabilities (Quarter) stood at $357.0 million in 2021, then surged by 49.9% to $535.1 million in 2022, then skyrocketed by 82.61% to $977.2 million in 2023, then increased by 17.89% to $1.2 billion in 2024, then rose by 7.63% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.4 billion during Q1 2025.